Thea-Stat™
is a unique, patent-pending, theaflavin-enriched
tea extract which has been clinically studied
for its ability to significantly lower cholesterol
levels.
Thea-Stat
was tested in a clinical trial involving 240 men
and women for its ability to lower cholesterol.
After 12 weeks, significant reductions in total
cholesterol (11.3%) and LDL cholesterol (16.4%)
were observed compared with a placebo. No adverse
effects were reported. This may be the first well-documented
human trial to demonstrate an LDL-lowering ability
of a tea extract. Thea-Stat has been extensively
tested and has been shown to be free of pesticides.†
Tea is
derived from the plant Camellia sinensis, and has
been used for many centuries as a popular
beverage worldwide. Amazingly, green and black
tea are made from the same plant, with black tea
being created via the oxidation of green tea leaves.
Both
forms of tea are a rich source of flavonoids, a
class of phytochemicals that are potent antioxidants
and support immune function and cardiovascular
health.
Most recently, there has been an increased focus
on studying the ability of tea to beneficially
modulate cholesterol levels. Observational studies
in humans
as well as studies in animals indicate that the
consumption of green and black tea may provide
beneficial outcomes
for blood lipid profiles and it is proposed that
theaflavins may play a very important role.
